Cancer Trials Support Unit
@TheCTSU
Followers
437
Following
14
Media
0
Statuses
2K
The CTSU is a service of the NCI, providing information to qualified CTSU members at clinical sites and facilitating their access to NCI-funded clinical trials.
Joined February 2014
S1800E (#NCT06616584) Randomized Phase II/III Study of Docetaxel & Ramucirumab w/w/o Cemiplimab for Participants Previously Treated w/ Platinum-Based Chemo & Immunotherapy for Stage IV or Recurrent Non-Small Cell Lung Cancer has been approved for trial pre-activation.
0
0
0
EA2201 (#NCT04751370) A Phase II Study of Neoadjuvant Nivolumab Plus Ipilimumab and Short-Course Radiation in MSI-H/dMMR Locally Advanced Rectal Adenocarcinoma is closed to accrual effective 01/14/25. View the full memorandum in Protocol Updates on the CTSU members’ homepage.
0
0
0
A022004 (#NCT05710406) Randomized Trial of Consolidation Targeted Adjuvant Therapy w/ Encorafenib & Cetuximab v. Usual Care for Patients w/ Stage II/III BRAF V600E Colon Cancer is closed to accrual effective 12/20/24. View full memorandum in Protocol Updates on the CTSU homepage.
0
0
0
RT @ALLIANCE_org: #ICYMI - .@stuchman1 @UNC_Lineberger leads @ALLIANCE_org A062102, a trial that compares iberdomide maintenance therapy to….
0
4
0
The most fun image & video creation tool in the world is here. Try it for free in the Grok App.
0
1K
9K
RT @eaonc: #ClinicalTrial EAQ222CD/CostCOM, led by @GelarehSadigh, is testing the effectiveness of cost communication and financial navigat….
0
1
0
RT @eaonc: .@skmaithel of @WinshipAtEmory is leading EA2197/OPT-IN, a #ClinicalTrial for patients with incidentally discovered stage 2-3 #G….
0
1
0
RT @eaonc: EA1211/DIRECT aims to help doctors make better (more personalized) decisions around treatment for #patients with #HER2positive #….
0
1
0
WF2304-A172401 (#NCT06418204) Complementary Options for Symptom Management In Cancer: Assessing Benefits and Harms of Cannabis & Cannabinoid Use Among a Cohort of Cancer Patients Treated in Community Oncology Clinics was activated on 1/15/24.
0
0
0
EA2212 (#NCT05836584) Randomized Phase II Study of Perioperative Atezolizumab +/- Chemotherapy in Resectable MSI-H/dMMR Gastric & Gastroesophageal Junction Cancer is closed to accrual effective 12/4/24. View the full memorandum in Protocol Updates on the CTSU members’ homepage.
0
0
0
10347 (#NCT04652960) A Phase I Study with an Expansion Cohort of Duvelisib and Nivolumab in Mycosis Fungoides (MF) and Sézary Syndrome (SS) is closed to accrual effective 12/24/24. View the full memorandum in Protocol Updates on the CTSU members’ homepage.
0
0
0
S2015 (#NCT00352222) Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma was reactivated on 01/09/25. View full memorandum in Protocol Updates on CTSU.
0
0
0
RT @eaonc: The EA3202 clinical study is comparing three possible treatment approaches for patients with advanced-stage #HeadAndNeckCancer t….
0
1
0
RT @eaonc: #ClinicalTrial EA7211/STRASS 2, led in the US by @kencardonaMD, is the second randomized study ever performed in retroperitoneal….
0
1
0
RT @ALLIANCE_org: #ICYMI: Steven Schild MD @MayoClinic .@ChristineBestv1 @UChicagoMed lead @ALLIANCE_org A082002, a trial for patients with….
0
1
0
RT @eaonc: #ClinicalTrial EAA173/DETER-SMM, led by @nsc_natalie of @UWCarbone, is a randomized phase 3 trial for patients with smoldering #….
0
1
0
RT @eaonc: The EAF223/GABLE clinical study is testing different imaging techniques that could help make better predictions about #BrainCanc….
0
1
0
RT @eaonc: In phase 2 #ClinicalTrial EA1211/DIRECT, researchers are using an #imaging test called a FDG-PET/CT scan to try to better predic….
0
1
0
RT @eaonc: In the #ComboMATCH Study, researchers are testing if genetically-matched drug combinations will be more effective than single dr….
0
1
0